Copyright
©The Author(s) 2018.
World J Diabetes. Dec 15, 2018; 9(12): 230-238
Published online Dec 15, 2018. doi: 10.4239/wjd.v9.i12.230
Published online Dec 15, 2018. doi: 10.4239/wjd.v9.i12.230
Glucose-lowering agents | Cardiorespiratory fitness |
Metformin | → or ↓ |
Thiazolidinediones | ↑ |
DPP-4 inhibitors | Unknown |
(↑ in mice with heart failure) | |
GLP-1 receptor agonists | ↑ in patients with heart failure |
→ in patients with type 2 diabetes | |
SGLT2 inhibitors | ↑ in patients treated with loop diuretics |
- Citation: Hamasaki H. Effects of glucose-lowering agents on cardiorespiratory fitness. World J Diabetes 2018; 9(12): 230-238
- URL: https://www.wjgnet.com/1948-9358/full/v9/i12/230.htm
- DOI: https://dx.doi.org/10.4239/wjd.v9.i12.230